What is IPO Grey Market Premium (GMP)?

IPO Grey Market Premium (GMP) is an unofficial, over-the-counter premium over the issue price that dealers and investors pay prior to official listing on NSE/BSE.

How is estimated IPO listing price determined?

Estimated Listing Price = Cut-off / Issue Price + Current Grey Market Premium (GMP). For example, an issue price of ₹100 with ₹40 GMP yields an estimated listing price of ₹140 (+40%).

What is Kostak rate in an IPO?

Kostak rate is the fixed profit earned by selling an IPO application before allotment, irrespective of whether the application is allotted shares or not.

What is Subject to Sauda in IPO trading?

Subject to Sauda is an informal contract where payment is made only if the seller receives share allotment in the IPO.

Is IPO Grey Market Premium (GMP) regulated by SEBI?

No. Grey Market transactions are non-exchange over-the-counter commitments and are not officially regulated or endorsed by SEBI. Investors should treat GMP as an informal sentiment indicator.

What is the estimated listing price for Suraksha Diagnostic Limited IPO?

Based on the upper price band of ₹441 and current GMP of ₹13, the estimated listing price is ₹454 (approx. 3.0% gain).

What is the expected profit per lot for Suraksha Diagnostic Limited IPO?

With a lot size of 34 shares and current GMP of ₹13, expected profit per retail application lot is approximately ₹442.

IPO GreyPremiumLIVE

Grey Market Intelligence

Suraksha Diagnostic Limited

ListedMainboard

Healthcare Services · NSE / BSE

Suraksha Diagnostic Limited, incorporated on March 15, 2005, is a technology-driven diagnostic chain offering integrated pathology, radiology, and medical consultancy services. The company provides over 2,300 tests across multiple specialties through a network that includes a central reference laboratory, 8 satellite laboratories, and 194 customer touchpoints, comprising 48 diagnostic centers and 146 sample collection centers. Additionally, 43 diagnostic centers house 120 polyclinics staffed by over 750 doctors, providing online and offline consultations. Leveraging advanced technology such as LIMS, RIS, PACS, and ERP systems, Suraksha Diagnostic enhances operational efficiency and reduces turnaround times. The company also offers vaccination services, customized testing packages for early disease detection, and AI-driven digital pathology solutions, with all radiology reports digitally processed to enable seamless reporting across centers.

Price Band

₹420 – ₹441

Issue Size

₹846 Cr

Lot Size

34 shares

GMP

₹13

+3.0%

Est. Listing

₹454

at current GMP

Subscribed

1.27x

overall

Open

29 Nov 2024

3 Dec 2024

Allotment

4 Dec 2024

Refund

5 Dec 2024

Demat Credit

6 Dec 2024

Listing

6 Dec 2024

Last updated 12 days ago

Overview Live GMP Live Subscription Allotment Status

Live Grey Market Premium

Suraksha Diagnostic Limited GMP Today

Last updated: 19 Oct 2026

Current Premium

₹13+3.0%

Issue Price (Upper)

₹441

Band: ₹420 – ₹441

Estimated Listing Price

₹454

Upper price + GMP

Lot Size

34 shares

Min investment ₹14,994

Date	GMP (₹)	GMP %	Est. Listing
31 Oct 2026	+₹13	3.0%	₹454
30 Oct 2026	+₹13	3.0%	₹454
29 Oct 2026	+₹12	2.6%	₹453

About Suraksha Diagnostic Limited Public Issue & Market Profile

Suraksha Diagnostic Limited is bringing an initial public offering (IPO) in the Healthcare Services sector with an aggregate issue size of ₹846.25 Crores. The shares are offered at a price band of ₹420 to ₹441 per equity share on NSE and BSE. Currently, grey market participants and retail investors are watching the bidding trend, premium movement, and anchor book demand with keen interest.

Public Issue & Pricing Context:

Prospective investors can apply in the retail quota with a minimum of 1 lot comprising 34 shares (approx. ₹14,994 minimum investment). High net-worth individuals (HNI/NII) can bid in the sHNI (₹2 Lakh to ₹10 Lakh) or bHNI (above ₹10 Lakh) categories for enhanced quota allocation.

Basis of Allotment & Listing Timeline:

Allotment reconciliation will be managed by Kfin Technologies Limited. Eligible allottees will receive credit of equity shares into their Demat accounts by 2024-12-06, while un-allotted funds or UPI block mandates will be released on 2024-12-05.

Frequently Asked Questions

What is Suraksha Diagnostic Limited IPO GMP today?

The latest grey market premium for Suraksha Diagnostic Limited IPO is ₹13, which indicates an expected listing price of ₹454.

What does Kostak Rate and Sauda mean in IPO GMP?

Kostak rate is the profit amount an investor earns by selling their entire IPO application in the grey market before allotment is finalized.

Is Grey Market Premium officially recognized?

No. GMP is an unofficial indicator discovered between dealers outside of SEBI-regulated exchanges. Actual listing price is determined by demand-supply discovery on NSE/BSE during the pre-open auction.